For the year ending 2025-12-31, CPHI had -$281,767 decrease in cash & cash equivalents over the period. $88,937 in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -3,187,556 |
| Depreciation and amortization | 1,503,635 |
| Depreciation of right of use assets | 75,534 |
| Accounts written off to allowance for credit losses | -13,664,945 |
| Financial expense | -3,472 |
| Credit (gains) loss | -1,018 |
| Provision to write down inventories to net realizable value | -549,218 |
| Trade accounts and other receivables | -13,208,415 |
| Advances to suppliers | -8,334 |
| Inventories | -589,761 |
| Trade accounts payable | 650,309 |
| Other payables and accrued expenses | 465,753 |
| Contract liabilities | -53,444 |
| Prepaid expenses | -793 |
| Net cash provided by / (used in) operating activities | 148,261 |
| Purchases of property, plant and equipment, net | 59,324 |
| Advances for intangible assets | 77,927 |
| Net cash used in investing activities | -137,251 |
| Payments of line of credit | 1,176,343 |
| Proceeds from lines of credit | 699,996 |
| Proceeds from related party | 261,070 |
| Principal payments on finance lease liabilities | 78,750 |
| Net cash used in financing activities | -294,027 |
| Effect of exchange rate changes on cash | 1,250 |
| Net decrease in cash and cash equivalents | -281,767 |
| Cash and cash equivalents at beginning of year | 626,879 |
| Cash, cash equivalents and restricted cash at end of year | 345,112 |
CHINA PHARMA HOLDINGS, INC. (CPHI)
CHINA PHARMA HOLDINGS, INC. (CPHI)